Chemotherapy: Take the pros.

Forget the cons.

And get better results.

Nanoparticle-delivered,
Ultrasound-activated,
Platinum-based Chemotherapy

Take a look at a short and simple explanation of our approach.

Discover Our Approach

We are pioneering the next generation of cancer treatment in chemotherapy

Welcome to the future of cancer treatment. Welcome to NUP-CTx. We are operating at the forefront of revolutionary chemotherapy solutions. Our innovative technique merges advanced nanotechnology with biochemistry, transforming potent platinum-based chemotherapy drugs into safe and stable prodrugs, which are encapsulated within our specially designed nanospheres, equipped with molecular antennas.

Our innovative approach combines cutting-edge nanotechnology and biochemistry.

  1. Transform an aggressive platinum-based chemotherapy drug into a safe and stable prodrug and encapsulate the prodrug within specially designed nanospheres containing molecular antennas.

  2. Deliver the nanospheres directly to the tumor via a simple infusion.

  3. Ignite the nanospheres with a simple ultrasound-activation. This transforms the prodrug into an active platinum-based chemotherapy agent, releasing it directly into the tumor.

special feature

Why NUP-CTx?

  • Reduced Side Effects Our ultrasound-activated approach spares healthy tissues, significantly minimizing the harsh side effects commonly associated with traditional chemotherapy.
  • Precision Targeting Our nanoparticles ensure that the chemotherapy drug reaches the tumor site with precise accuracy. The nanoparticles do not affect other parts of the body.
  • Proven Effectiveness Our groundbreaking method - chemotherapy without the debilitating side effects - has shown promising results in preclinical studies, effectively shrinking and even eradicating tumors.
  • Future-Ready Potential Our flexible platform is designed to evolve and be expanded, allowing us to adapt it to treat various types of cancer as research progresses.
Logo Paul Ehrlich and Ludwig Darmstaedter Early Career Prize

"For his groundbreaking invention of our innovative chemotherapy approach, our CSO, Dr. Johannes Karges, has been awarded the prestigious Paul Ehrlich and Ludwig Darmstaedter Early Career Prize. This prize is one of the most esteemed and recognized honors in the field of medicine in Germany, with many recipients later celebrated as Nobel Prize winners."

More news

Join Us in Pioneering Cancer Treatment

Explore the future of chemotherapy with NUP-CTx’s groundbreaking nanoparticle-delivered, ultrasound-activated platinum-based therapy. This cutting-edge approach ensures precise targeting, enhanced efficacy, and reduced toxicity, offering new hope in the battle against cancer.

Learn more about our Science